Investing.com - Pharvaris BV reported on Monday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Pharvaris BV announced earnings per share of €-0.38 on revenue of €0.00. Analysts polled by Investing.com anticipated EPS of €-0.5654 on revenue of €0.00.
Pharvaris BV shares are down 35% from the beginning of the year and are trading at €9.31 , down-from-52-week-high.
Pharvaris BV shares gained 0.59% in intra-day trade after the report.
Pharvaris BV follows other major Healthcare sector earnings this month
Pharvaris BV's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of €1.13 on revenue of €7.37B, compared to forecasts EPS of €1.12 on revenue of €7.22B.
Merck ADR had beat expectations on Friday with third quarter EPS of €0.5392 on revenue of €5.69B, compared to forecast for EPS of €0.5165 on revenue of €5.57B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar